These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 8087794)

  • 21. Long-term cancer patient survival in the United States.
    Wingo PA; Ries LA; Parker SL; Heath CW
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):271-82. PubMed ID: 9568781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer in patients with esophageal adenocarcinoma.
    Vaughan TL; Kiemeney LA; McKnight B
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):93-7. PubMed ID: 7742728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
    Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
    Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of Medicare claims data for estimation of cancer incidence and resection rates among elderly Americans.
    Whittle J; Steinberg EP; Anderson GF; Herbert R
    Med Care; 1991 Dec; 29(12):1226-36. PubMed ID: 1745080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of trends in age-adjusted incidence rates for 10 major sites of cancer.
    Sullivan PD; Christine B; Connelly R; Barrett H
    Am J Public Health; 1972 Aug; 62(8):1065-71. PubMed ID: 5046446
    [No Abstract]   [Full Text] [Related]  

  • 26. Differences in cancer incidence and mortality among socio-economic groups.
    van Loon AJ; Brug J; Goldbohm RA; van den Brandt PA; Burg J [corrected to Brug J]
    Scand J Soc Med; 1995 Jun; 23(2):110-20. PubMed ID: 7676217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Old age and cancer. Various epidemiologic aspects].
    de Mulder PH
    Tijdschr Gerontol Geriatr; 1986 Apr; 17(2):45-8. PubMed ID: 3715961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlations of incidence rates for selected cancers in the nine areas of the Third National Cancer Survey.
    Winkelstein W; Sacks ST; Ernster VL; Selvin S
    Am J Epidemiol; 1977 May; 105(5):407-19. PubMed ID: 871117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
    Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
    JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer trial enrollment after state-mandated reimbursement.
    Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
    J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cancer experience in the Framingham Heart Study cohort.
    Kreger BE; Splansky GL; Schatzkin A
    Cancer; 1991 Jan; 67(1):1-6. PubMed ID: 1845934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer in developing countries.
    Parkin DM
    Cancer Surv; 1994; 19-20():519-61. PubMed ID: 7534640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in cancer incidence in Connecticut.
    Polednak AP
    Conn Med; 1997 Apr; 61(4):211-8. PubMed ID: 9149483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer mortality surveillance--United States, 1990-2000.
    Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA
    MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of migrant population in studies of selected cancer sites: a review.
    Kmet J
    J Chronic Dis; 1970 Nov; 23(5):305-24. PubMed ID: 4923942
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer in older persons. Magnitude of the problem--how do we apply what we know?
    Yancik R; Ries LA
    Cancer; 1994 Oct; 74(7 Suppl):1995-2003. PubMed ID: 8087762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer trends among the extreme elderly in the era of cancer screening.
    Becker D; Ryemon S; Gross J; Levy B; Grossbard M; Ennis R
    J Geriatr Oncol; 2014 Oct; 5(4):408-14. PubMed ID: 25108886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients.
    Devine PL; McGuckin MA; Ramm LE; Ward BG; Pee D; Long S
    Cancer; 1993 Sep; 72(6):2007-15. PubMed ID: 7689923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program.
    Lyss AP; Lilenbaum RC
    Clin Lung Cancer; 2009 Nov; 10(6):410-3. PubMed ID: 19900858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States.
    Yu H; Harris RE; Gao YT; Gao R; Wynder EL
    Int J Epidemiol; 1991 Mar; 20(1):76-81. PubMed ID: 2066247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.